Alithea Genomics, an emerging leader in large-scale RNA sequencing and transcriptomics, has closed a CHF 6.9 M ($8.9 million) seed round.

Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...

Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered ...

Gordian Biotechnology, a biotechnology company focused on discovering and validating therapeutic targets through causal biology, today announced the release of a new preprint, titled: "A Multispecies, ...

UD developmental biologist studies genetics of jaw joint disorder with NIH funding ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with Unilever, a global leader in consumer goods. The partnership will ...

The human lymphatic system is notoriously difficult to map due to its size and variability among individuals. Spatial ...

In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ...